Clinuvel Pharmaceuticals SEC Filings
NASDAQ: CUVLMiscellaneousMiscellaneousUSD
5.59-0.01 (-0.18%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Clinuvel Pharmaceuticals filing overview
This page lists 16 recent SEC filings by Clinuvel Pharmaceuticals (CUVL), including 13 6-K, 3 424B3. Form 10-K is the audited annual report, 10-Q the quarterly report, 8-K covers material events, and Form 4 reports insider transactions. All documents link directly to SEC EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
CUVL SEC filings
| Filed | Form | Description | Document |
|---|---|---|---|
| Oct 7, 2026 | 6-K | Report of foreign private issuer | View on EDGAR |
| Oct 2, 2026 | 6-K | Report of foreign private issuer | View on EDGAR |
| Oct 1, 2026 | 6-K | Report of foreign private issuer | View on EDGAR |
| Sep 9, 2026 | 6-K | Report of foreign private issuer | View on EDGAR |
| Aug 27, 2026 | 6-K | Report of foreign private issuer | View on EDGAR |
| Aug 20, 2026 | 6-K | Report of foreign private issuer | View on EDGAR |
| Aug 12, 2026 | 6-K | Report of foreign private issuer | View on EDGAR |
| Jul 30, 2026 | 6-K | Report of foreign private issuer | View on EDGAR |
| Jul 28, 2026 | 6-K | Report of foreign private issuer | View on EDGAR |
| Jul 27, 2026 | 6-K | Report of foreign private issuer | View on EDGAR |
| Jul 23, 2026 | 6-K | Report of foreign private issuer | View on EDGAR |
| Jul 22, 2026 | 6-K | Report of foreign private issuer | View on EDGAR |
| Jul 22, 2026 | 6-K | Report of foreign private issuer | View on EDGAR |
| Jul 17, 2026 | 424B3 | Prospectus | View on EDGAR |
| Nov 26, 2010 | 424B3 | Prospectus | View on EDGAR |
| Mar 20, 2006 | 424B3 | Prospectus | View on EDGAR |